FDA Inspection 1329796 — Alejandra M. Villamil, M.D.
The FDA completed an inspection of Alejandra M. Villamil, M.D. on Aug 7, 2026 in Ciudad Autonoma Buenos Aires. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 7, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ciudad Autonoma Buenos Aires (Argentina)
Additional Details
Clinical Investigator (CI)